Armistice Capital, Llc Vaxart, Inc. (VXRT) insider trading activity

Armistice Capital, LLC is Director of Vaxart, Inc.. Currently has a direct ownership of 145,523 shares of VXRT, which is worth approximately $101,866. The most recent transaction as insider was on Apr 28, 2020, when has been sold 1,292,070 shares (Common Stock) at a price of $3.38 per share, resulting in proceeds of $4,367,197. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 146K

0% 3M change

0% 12M change

Total Value Held $101,866

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 28 2020	SELL Open market or private sale	$4,367,197 $3.38 p/Share	1,292,070 Reduced 5.13%	23,907,930 Common Stock
Nov 07 2019	BUY Open market or private purchase	$21,675 $0.34 p/Share	63,749 Added 0.25%	25,200,000 Common Stock
Nov 06 2019	BUY Open market or private purchase	$21,035 $0.34 p/Share	61,869 Added 0.25%	25,136,251 Common Stock
Nov 05 2019	BUY Open market or private purchase	$24,546 $0.33 p/Share	74,382 Added 0.3%	25,074,382 Common Stock
Oct 07 2019	BUY Open market or private purchase	$107,300 $0.37 p/Share	290,000 Added 1.15%	25,000,000 Common Stock
Oct 04 2019	BUY Open market or private purchase	$95,900 $0.35 p/Share	274,000 Added 1.1%	24,710,000 Common Stock
Oct 03 2019	BUY Open market or private purchase	$77,765 $0.34 p/Share	228,720 Added 0.93%	24,436,000 Common Stock

Oct 02 2019	BUY Open market or private purchase	$8,609 $0.36 p/Share	23,913 Added 0.1%	24,207,280 Common Stock
Oct 01 2019	BUY Open market or private purchase	$64,178 $0.35 p/Share	183,367 Added 0.75%	24,183,367 Common Stock
Sep 30 2019	BUY Open market or private purchase	$528,124 $0.33 p/Share	1,600,376 Added 6.25%	24,000,000 Common Stock
Sep 27 2019	BUY Open market or private purchase	$282,066 $0.29 p/Share	972,643 Added 4.16%	22,399,624 Common Stock
Sep 26 2019	BUY Open market or private purchase	$1,332,888 $0.28 p/Share	4,760,314 Added 18.18%	21,426,981 Common Stock

Also insider at

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL